secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001213900-25-041653
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to June 11, 2025 with $874.78 trust deposit funded by Scilex note
--------------------------------------------------------------------------------

- Deposited $874.78 into trust account to extend deadline from May 11 to June 11, 2025.
- Deposit funded by convertible promissory note from Scilex (SCLX) with principal up to $180,000, no interest.
- Note convertible at Scilex's discretion into Class A shares at $10.00 per share upon business combination close.
- Remaining $57,795.52 available under note expected to fund future one-month extensions if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025041653/0001213900-25-041653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025041653/ea0241580-8k425_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-041653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer